- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/24 - Radicals substituted by nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 233/24
Total number of patents in this class: 76
10-year publication summary
|
5
|
7
|
3
|
2
|
7
|
6
|
3
|
2
|
4
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7937 |
6 |
| Bayer Pharma AG | 1048 |
6 |
| Opus Genetics, Inc. | 43 |
4 |
| Hexion Inc. | 219 |
3 |
| Spirify Pharma Inc | 9 |
3 |
| Allergan, Inc. | 2313 |
2 |
| Centre National de La Recherche Scientifique | 10706 |
2 |
| The Board of Trustees of the University of Illinois | 2724 |
2 |
| Mitsubishi Gas Chemical Company, Inc. | 3509 |
2 |
| Stepan Company | 574 |
2 |
| Tohoku University | 2849 |
2 |
| The University of Tokyo | 4250 |
2 |
| Kirin Holdings Company, Limited | 239 |
2 |
| Halliburton Energy Services, Inc. | 21090 |
1 |
| BASF SE | 21098 |
1 |
| The Regents of the University of California | 20303 |
1 |
| Syngenta Participations AG | 1730 |
1 |
| Syngenta Crop Protection AG | 6259 |
1 |
| Toshiba Corporation | 12547 |
1 |
| Massachusetts Institute of Technology | 10150 |
1 |
| Other owners | 31 |